LOXL2 and esophageal squamous cell carcinoma: Clinical data suggested that positive LOXL2 expression was associated with lymph node metastasis, so a Transwell assay was performed on ESCC cells to assess the effect of LOXL2 silencing and overexpression on the apoptotic, migratory, and invasive capacity of ESCC cells.